Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Epoetin · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | - |
| 2 | ACTIVE_COMPARATOR | - |
| Name | Type | Description |
|---|---|---|
| epoetin | DRUG | 3 times a week iv, as prescribed. |
| methoxy polyethylene glycol-epoetin beta [Mircera] | DRUG | 0.4 micrograms/kg iv (starting dose) once every 2 weeks |
Inclusion Criteria: * adult patients \>=18 years of age; * chronic renal anemia; * dialysis therapy for at least 2 weeks before screening. Exclusion Criteria: * women who are pregnant, breastfeeding or using unreliable birth control methods; * administration of any investigational drug within 4 w...